1 Adolescent Substance Use and Addiction Program, Division of Developmental Medicine, Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
2 Division of Adolescent Medicine, Department of Pediatrics, Sainte-Justine University Hospital Centre, University of Montreal, Montreal, Quebec, Canada566633.
3 Department of Analytics, Children's Hospital Association, Lenexa, Kansas.
4 Boston University School of Public Health, Boston, Massachusetts.
5 Center for Health Services & Society, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles.
6 Section of General Internal Medicine, Department of Medicine and Division of General Pediatrics, Department of Pediatrics, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts.
7 Division of General Pediatrics, Department of Pediatrics, Boston University School of Medicine, Boston, Massachusetts.
This study assesses use of nicotine replacement therapy, varenicline, and sustained-release bupropion for adolescents and young adults with nicotine use disorder who are enrolled in Medicaid.